Related Experiment Video
Updated: Apr 12, 2026

Author Spotlight: Enhancing Cerebral Ischemia Research with a Simplified Rat Model
Published on: July 5, 2024
Association between PDE4D gene and ischemic stroke: recent advancements
Satrupa Das1,2, Sitara Roy1,2, Anjana Munshi3
1a Department of Molecular Biology, Institute of Genetics and Hospital for Genetic Diseases , Osmania University , Begumpet , Hyderabad , India.
Genetic studies reveal the phosphodiesterase 4D (PDE4D) gene plays a key role in stroke development and outcomes globally. This gene presents a potential drug target for managing ischemic stroke, warranting further research.
Area of Science:
- Genetics
- Molecular Biology
- Pharmacology
Background:
- Stroke is a major global cause of death and disability.
- Genetic studies implicate phosphodiesterase 4D (PDE4D) in cerebrovascular diseases.
- PDE4D gene variants are linked to stroke risk in specific ethnicities.
Purpose of the Study:
- To review recent advancements in PDE4D gene research related to stroke.
- To explore the genetic, molecular, and pharmacological aspects of PDE4D in stroke.
- To assess PDE4D as a potential therapeutic target for stroke management.
Main Methods:
- Review of recent genetic, molecular, and pharmacological studies on PDE4D and stroke.
- Analysis of case-control and meta-analysis findings.
- Synthesis of evidence on PDE4D's role in stroke development and outcome.
Main Results:
- Strong evidence supports the pivotal role of the PDE4D gene in ischemic stroke.
- Specific PDE4D variants are associated with stroke predisposition in certain ethnic groups.
- PDE4D influences stroke development and may impact patient outcomes.
Conclusions:
- The PDE4D gene is a significant factor in global ischemic stroke.
- The PDE4D pathway is a promising drug target for stroke management.
- Further research is needed to elucidate the intricate molecular and cellular mechanisms of PDE4D in stroke.
More Related Videos
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Peripheral Artery Disease I: Introduction
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Regulation of Stroke Volume
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Pharmacogenomics: Identification of New Drug Targets
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...

